EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quality of Life and Costs Within Decongestive Lymphatic Therapy in Patients with Leg Lymphedema: A Multicountry, Open-Label, Prospective Study

Peter J Franks, Isabelle Quéré iD, Vaughan Keeley iD, Andrea Tilley, Max Liebl, Susie Murray, Ewa A Burian, Christine J Moffatt iD

Lymphatic Research and Biology · 01.10.2021 · 19 (5) · 423-430

DOI: 10.1089/lrb.2021.0057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lymphatic Research and Biology, online erschienen am 15.10.2021. Verfasst von Peter J Franks und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research and Implementation of Clinical Practice, London, United Kingdom. Hauptthemen laut MEDLINE: Lymphedema, Quality of Life. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Little is known of the impact in terms of health-related quality of life (HRQoL) and cost-effectiveness with decongestive therapy.

Objectives

To examine changes in limb volume, quality of life (QoL), and treatment cost of methods of decongestive lymphatic therapy (DLT).

Methods

Patients with chronic edema/lymphedema of the leg were invited to participate in a study of DLT in four countries (United Kingdom, France, Germany, and Canada). In each country two sites were selected. One site used their standard method of DLT in their service, including compression with multilayer bandaging with inelastic material. The other site used a system that included 3M™ Coban 2™ as the bandage treatment alongside other standard components of DLT. Patients were followed for either 2 or 4 weeks depending on the local protocols. At entry, at 2 weeks, and at 4 weeks, patients were assessed by using a health index (EQ-5D), a disease-specific HRQoL tool (LYMQOL) and resource usage was recorded over the treatment period.

Results

Of the 165 patients with cost data, 90 were treated with Coban 2 and 75 with standard care compression bandaging. There was good evidence of an improvement in EQ-5D of 0.077 ( p < 0.001) in all patients. LYMQOL showed significant improvements ( p < 0.001) with lower scores. There were no major differences between the two arms of the study with respect to HRQoL. The number of treatment episodes was higher in those treated with standard care (8.15 vs. 6.37), but the overall treatment cost was higher with Coban 2 (£890.7) compared with standard care (£723.0).

Conclusion

QoL improved in the standard care and Coban 2 group bandages, and there was no demonstrable difference between the care systems. Further work is required to examine the role of the individual parts of DLT that provide the greatest benefit to patients and the health systems that support them.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphedemaQuality of LifeCompression BandagesHumansLegProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

chronic edemacost-effectivenessdecongestive lymphatic therapyhealth-related quality of life

Autor:innen und Institutionen

  • Centre for Research and Implementation of Clinical Practice, London, United Kingdom.
  • National Reference Centre for Rare and Vascular Diseases, Chu-Montpellier, France.
  • Department of Vascular Medicine, UMR IDESP, Université de Montpellier, Chu-Montpellier, France.
  • Lymphoedema Department, University Hospitals of Derby and Burton NHS Trust, Derby, United Kingdom.
  • School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Archstone Physiotherapy and Wellness Centre, St. John, Canada.

ORCID-Profile: Isabelle Quéré, Vaughan Keeley, Christine J Moffatt

Zitieren

APA

Franks, P. J., Quéré, I., Keeley, V., Tilley, A., Liebl, M., Murray, S., Burian, E. A., & Moffatt, C. J. (2021). Quality of Life and Costs Within Decongestive Lymphatic Therapy in Patients with Leg Lymphedema: A Multicountry, Open-Label, Prospective Study. Lymphatic Research and Biology, 19(5), 423-430. https://doi.org/10.1089/lrb.2021.0057

Vancouver

Franks PJ, Quéré I, Keeley V, Tilley A, Liebl M, Murray S, et al. Quality of Life and Costs Within Decongestive Lymphatic Therapy in Patients with Leg Lymphedema: A Multicountry, Open-Label, Prospective Study. Lymphatic Research and Biology. 2021;19(5):423-430. doi:10.1089/lrb.2021.0057

BibTeX
@article{Franks2021,
  author = {Franks, Peter J and Quéré, Isabelle and Keeley, Vaughan and Tilley, Andrea and Liebl, Max and Murray, Susie and Burian, Ewa A and Moffatt, Christine J},
  title = {Quality of Life and Costs Within Decongestive Lymphatic Therapy in Patients with Leg Lymphedema: A Multicountry, Open-Label, Prospective Study},
  journal = {Lymphatic Research and Biology},
  year = {2021},
  volume = {19},
  number = {5},
  pages = {423--430},
  doi = {10.1089/lrb.2021.0057}
}
Kostenlos starten →